LAUSR

&NA; Despite rapid progress in the understanding of systemic lupus erythematosus (SLE), there is still an urgent need for novel and more effective interventions. Curcumin, a natural polyphenol compound, has been shown to be anti‐inflammatory in various disorders. In this study, we investigated the potential therapeutic value of curcumin in SLE. Lupus‐prone female MRL/lpr mice were treated with curcumin. The development and extent of nephritis were assessed by monitoring proteinuria and by histologic analysis. Serum anti‐dsDNA levels were measured by enzyme‐linked immunosorbent assay. Kidney samples were analyzed by Western blot. In vitro, mouse podocytes were used for investigation in the presence of mouse anti‐dsDNA antibody‐positive (anti‐dsDNA+) serum. Curcumin treatment dramatically decreased proteinuria and renal inflammation. Serum anti‐dsDNA levels and spleen size were also reduced by curcumin. In addition, curcumin reduced NLRP3 inflammasome activation in lupus‐prone mice. In vitro, curcumin significantly inhibited anti‐dsDNA+ serum induced expression of NLRP3 inflammasome in podocytes. Overall, these data demonstrate the potential use of curcumin in SLE treatment.